Scientists devise new strategy to destroy multiple myeloma
A study published online in the journal Cancer Research details a dramatic increase in multiple myeloma cell death caused by a combination of the drugs obatoclax and flavopiridol. The researchers, led by Steven Grant, M.D., Shirley Carter Olsson and Sture Gordon Olsson Chair in Oncology Research, associate director for translational research, program co-leader and member of Developmental Therapeutics and member of the Cancer Cell Signaling program at VCU Massey Cancer Center, found that the two drugs worked together through different mechanisms to promote a form of cell suicide known as apoptosis.
Massey rated the top cancer center in Virginia by U.S. News
As reported in the July issue, U.S. News & World Report rated Virginia Commonwealth University Massey Cancer Center the top hospital in Virginia providing high-performing cancer care in the publication’s annual Best Hospitals list. Ranked the No.1 hospital overall at the top of all 127 Virginia and 21 Richmond metropolitan hospitals is VCU Medical Center, which includes Massey’s oncology patient care.
Interactive personal health records increase clinical preventive services
Patients who use an interactive personal health record (IPHR) are almost twice as likely to be up to date with clinical preventive services as those who do not, according to a new study led by Alex Krist, M.D., M.P.H., research member of the Cancer Prevention and Control program at Virginia Commonwealth University Massey Cancer Center.
Antibodies from rabbits reduce risks associated with unrelated donor stem cell transplantation
Researchers at Virginia Commonwealth University (VCU) Massey Cancer Center‘s Bone Marrow Transplant Program have demonstrated that the use of antibodies derived from rabbits can improve the survival and relapse outcomes of leukemia and myelodysplasia patients receiving a stem cell transplant from an unrelated donor.